Cibus (CBUS) Revenue (2016 - 2026)
Cibus (CBUS) posted Revenue of $1.1 million for Q4 2025, up 71.87% sequentially from $615000.0 in Q3 2025, and down 12.79% YoY from $1.2 million in Q4 2024.
Cibus (CBUS) Revenue (2016 - 2026) Analysis & Trends
Cibus has reported Revenue for 10 years, with the latest figure at $1.1 million in Q4 2025.
- Quarterly Revenue fell 12.79% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (down 14.62% YoY) and the FY2025 annual result came in at $3.6 million, down 14.62% from the prior year.
- Revenue rose to $1.1 million in Q4 2025 per CBUS's latest filing, from $615000.0 in the prior quarter.
- Over five years, Revenue peaked at $11.9 million in Q2 2021 and troughed at $32000.0 in Q1 2022.
- A 5-year average of $1.8 million and a median of $885500.0 in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue tumbled 99.65% in 2022, then jumped 2526.19% in 2023.
- Over 5 years, Revenue stood at $1.9 million in 2021, then tumbled by 97.84% to $42000.0 in 2022, then surged by 2526.19% to $1.1 million in 2023, then increased by 9.88% to $1.2 million in 2024, then fell by 12.79% to $1.1 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $1.1 million, $615000.0, and $933000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 994,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 994,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 615,000.00 |
| Jun 30, 2025 | 933,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 838,000.00 |
| Mar 31, 2024 | 545,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 475,000.00 |
| Jun 30, 2023 | 197,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 42,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 1.94 Mn |
| Sep 30, 2021 | 7.76 Mn |
| Jun 30, 2021 | 11.88 Mn |